Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies
-
- Nathan D. Trinklein
- Teneobio, Inc., Menlo Park, CA, USA
-
- Duy Pham
- Teneobio, Inc., Menlo Park, CA, USA
-
- Ute Schellenberger
- Teneobio, Inc., Menlo Park, CA, USA
-
- Ben Buelow
- Teneobio, Inc., Menlo Park, CA, USA
-
- Andrew Boudreau
- Teneobio, Inc., Menlo Park, CA, USA
-
- Priya Choudhry
- Department of Laboratory Medicine, University of California, San Francisco, CA, USA
-
- Starlynn C. Clarke
- Teneobio, Inc., Menlo Park, CA, USA
-
- Kevin Dang
- Teneobio, Inc., Menlo Park, CA, USA
-
- Katherine E. Harris
- Teneobio, Inc., Menlo Park, CA, USA
-
- Suhasini Iyer
- Teneobio, Inc., Menlo Park, CA, USA
-
- Brett Jorgensen
- Teneobio, Inc., Menlo Park, CA, USA
-
- Payal P. Pratap
- Teneobio, Inc., Menlo Park, CA, USA
-
- Udaya S. Rangaswamy
- Teneobio, Inc., Menlo Park, CA, USA
-
- Harshad S. Ugamraj
- Teneobio, Inc., Menlo Park, CA, USA
-
- Omid Vafa
- Teneobio, Inc., Menlo Park, CA, USA
-
- Arun P. Wiita
- Department of Laboratory Medicine, University of California, San Francisco, CA, USA
-
- Wim van Schooten
- Teneobio, Inc., Menlo Park, CA, USA
-
- Roland Buelow
- Teneobio, Inc., Menlo Park, CA, USA
-
- Shelley Force Aldred
- Teneobio, Inc., Menlo Park, CA, USA
収録刊行物
-
- mAbs
-
mAbs 11 (4), 639-652, 2019-02-20
Informa UK Limited
